SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001493152-22-006504
Filing Date
2022-03-10
Accepted
2022-03-10 16:05:35
Documents
6

Document Format Files

Seq Description Document Type Size
1 formposam.htm POS AM 360631
2 ex23-1.htm EX-23.1 3363
3 formposam_001.jpg GRAPHIC 17256
4 formposam_002.jpg GRAPHIC 16948
5 ex23-1_001.jpg GRAPHIC 5607
6 ex23-1_002.jpg GRAPHIC 29015
  Complete submission text file 0001493152-22-006504.txt   460366
Mailing Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1
Business Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1 (604) 921-1810
BriaCell Therapeutics Corp. (Filer) CIK: 0001610820 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0731
Type: POS AM | Act: 33 | File No.: 333-257104 | Film No.: 22729058
SIC: 2834 Pharmaceutical Preparations